We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$18.4M
Cap. Flow
+$15.4M
Cap. Flow %
10.36%
Top 10 Hldgs %
23.06%
Holding
807
New
78
Increased
152
Reduced
163
Closed
88

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$837K
2
ENB icon
Enbridge
ENB
+$643K
3
ABBV icon
AbbVie
ABBV
+$597K
4
IVZ icon
Invesco
IVZ
+$518K
5
CVS icon
CVS Health
CVS
+$501K

Top Sells

Rank Stock Value
1
VGK icon
Vanguard FTSE Europe ETF
VGK
+$1.23M
2
DEM icon
WisdomTree Emerging Markets High Dividend Fund
DEM
+$1M
3
BX icon
Blackstone
BX
+$893K
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$869K
5
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$304K

Sector Composition

Rank Sector Weight
1 Technology 14.14%
2 Healthcare 10.85%
3 Consumer Staples 8.36%
4 Industrials 8.19%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SENS icon
601
Senseonics Holdings Inc
SENS
$366M
$6K ﹤0.01%
150
-65
-30% -$2.74K
TTC icon
602
Toro Company
TTC
$9.49B
$6K ﹤0.01%
87
– –
VNQ icon
603
Vanguard Real Estate ETF
VNQ
$39B
$6K ﹤0.01%
63
– –
VRTX icon
604
Vertex Pharmaceuticals
VRTX
$126B
$6K ﹤0.01%
31
– –
YUMC icon
605
Yum China
YUMC
$16.3B
$6K ﹤0.01%
120
– –
PRFT
606
DELISTED
Perficient Inc
PRFT
$6K ﹤0.01%
+186
New +$5.7K
CALA
607
DELISTED
Calithera Biosciences, Inc
CALA
$6K ﹤0.01%
78
– –
AKBA icon
608
Akebia Therapeutics
AKBA
$252M
$5K ﹤0.01%
935
– –
ARDX icon
609
Ardelyx
ARDX
$997M
$5K ﹤0.01%
1,779
– –
BIV icon
610
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$5K ﹤0.01%
58
– –
CCL icon
611
Carnival Corporation Ltd
CCL
$39.7B
$5K ﹤0.01%
100
– –
ECL icon
612
Ecolab
ECL
$79.9B
$5K ﹤0.01%
27
-53
-66% -$9.85K
GME icon
613
GameStop
GME
$8.6B
$5K ﹤0.01%
3,984
+268
+7% +$524
ILMN icon
614
Illumina
ILMN
$28.4B
$5K ﹤0.01%
+13
New +$4.11K
KEQU icon
615
Kewaunee Scientific
KEQU
$106M
$5K ﹤0.01%
250
– –
LABU icon
616
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$603M
$5K ﹤0.01%
+5
New +$4.84K
LOGI icon
617
Logitech
LOGI
$15.2B
$5K ﹤0.01%
+135
New +$5.26K
LPX icon
618
Louisiana-Pacific
LPX
$5.49B
$5K ﹤0.01%
187
– –
OMER icon
619
Omeros
OMER
$959M
$5K ﹤0.01%
350
– –
PPG icon
620
PPG Industries
PPG
$26.6B
$5K ﹤0.01%
47
– –
RGA icon
621
Reinsurance Group of America
RGA
$16.1B
$5K ﹤0.01%
32
– –
SLAB icon
622
Silicon Laboratories
SLAB
$7.23B
$5K ﹤0.01%
+53
New +$5.11K
UPLD icon
623
Upland Software
UPLD
$15.4M
$5K ﹤0.01%
+10
New +$4.58K
VFF icon
624
Village Farms International
VFF
$253M
$5K ﹤0.01%
+450
New +$5.7K
VLRS
625
Controladora Vuela Compania de Aviacion
VLRS
$939M
$5K ﹤0.01%
541
-2,826
-84% -$26.2K
23 24
25
26 27

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Truvestments Capital held 807 positions worth $149M, up 14% from $130M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Truvestments Capital deployed $15.4M of net new capital in Q2 2019, opening 78 new positions and adding to 152 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 4,043 shares worth $862K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $1.23M trimmed.

  • Truvestments Capital's largest Q2 2019 buy was Berkshire Hathaway Class B: 4,043 shares worth $862K.
  • Truvestments Capital added most to Enbridge in Q2 2019, an estimated $643K increase.
  • Truvestments Capital's biggest Q2 2019 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.23M.
  • Truvestments Capital fully exited Blackstone in Q2 2019, selling an estimated $893K.
  • Truvestments Capital's ten largest holdings make up 23% of its $149M portfolio in Q2 2019.
  • Truvestments Capital opened 78 new positions and closed 88 in Q2 2019.
  • Truvestments Capital's portfolio value rose 14% quarter-over-quarter to $149M.

Based on Truvestments Capital's 13F filing for Q2 2019, filed 15 Jul 2019.